Neuraminidase 1 Exacerbated Glycolytic Dysregulation and Cardiotoxicity by Destabilizing SIRT1 through Interactions with NRF2 and HIF1α
Advanced Science · 2025
DOI: 10.1002/advs.202414504 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Ting Gao und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China. Hauptthemen laut MEDLINE: Sirtuin 1, Glycolysis, NF-E2-Related Factor 2, Hypoxia-Inducible Factor 1, alpha Subunit. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Taishan Young Scholar Foundation of Shandong Province.
Abstract (Originalsprache)
Despite significant therapeutic advances, cumulative DOX‐induced cardiotoxicity (DIC) events remain unacceptably high. Recent evidence has underscored the critical role of impaired glycolytic metabolism in cardiovascular damage. Neuraminidase 1 (NEU1), a member of the neuraminidase family, catalyzes the hydrolysis of terminal sialic acids from glycoconjugates. Here, it is aimed to characterize the role of NEU1 on defective glycolysis during DIC. Mouse models with cardiac‐specific genetic modifications of Neu1 , Nrf2 , and Sirt1 underwent functional analyses, and RNA sequencing to clarify NEU1's role in glycolytic metabolism during DIC. It is discovered that NEU1 is highly expressed after DOX exposure and positively correlated with defective glycolysis phenotypes. Cardiomyocyte‐specific deficiency of Neu1 ameliorated impaired glycolytic metabolism and DIC, whereas overexpression of Neu1 in cardiomyocytes exacerbated these pathological phenotypes. Mechanistically, the upregulation of Neu1 is attributed to HIF1α’s transcriptional repression, which necessitated the collaboration of NRF2. Additionally, the C‐terminal region of NEU1 physically interacted with SIRT1, facilitating its lysosomal‐mediated degradation and contributing to the aberrant glycolytic phenotype. The pharmacological or genetic manipulation of NRF2 and HIF1α remarkably abolished DOX‐induced NEU1 upregulation, compromised glucose metabolism, and DIC progression. Collectively, NEU1 as a key regulator of cardiac glycolysis is established, offering new therapeutic avenues for DIC through maintaining metabolic flexibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.
- Department of Orthopedic Surgery, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, 250014, China.
- School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.
ORCID-Profile: Junlian Gu
Förderung
- National Natural Science Foundation of China
- Taishan Young Scholar Foundation of Shandong Province
Zitieren
APA
Gao, T., Tang, Y., Zeng, T., Wang, J., Zhang, X., Liu, Q., Guan, X., Tang, X., Lu, G., Li, J., Liu, M., Zhang, D., Lv, S., & Gu, J. (2025). Neuraminidase 1 Exacerbated Glycolytic Dysregulation and Cardiotoxicity by Destabilizing SIRT1 through Interactions with NRF2 and HIF1α. Advanced Science. https://doi.org/10.1002/advs.202414504
Vancouver
Gao T, Tang Y, Zeng T, Wang J, Zhang X, Liu Q, et al. Neuraminidase 1 Exacerbated Glycolytic Dysregulation and Cardiotoxicity by Destabilizing SIRT1 through Interactions with NRF2 and HIF1α. Advanced Science. 2025. doi:10.1002/advs.202414504
BibTeX
@article{Gao2025,
author = {Gao, Ting and Tang, Yufeng and Zeng, Tao and Wang, Jie and Zhang, Xiaohui and Liu, Qingbo and Guan, Xun and Tang, Xinyu and Lu, Guangping and Li, Jiahao and Liu, Mingrui and Zhang, Dongmei and Lv, Sixuan and Gu, Junlian},
title = {Neuraminidase 1 Exacerbated Glycolytic Dysregulation and Cardiotoxicity by Destabilizing SIRT1 through Interactions with NRF2 and HIF1α},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202414504}
}
EUVIMED